All Cases

Market Entry / Go-To-Market

Identified emotional drivers influencing treatment selection at specific points in the patient journey for a rare disease

Developed a market map to inform a mid-size GTx manufacturer’s commercial strategy and launch planning

Developed comprehensive approach to navigate international reimbursement for a GTx while managing channel-specific pricing considerations

Mapped key decisions and drivers of adoption for a blockbuster hematology product, informing strategic planning at a large pharmaceutical company looking to expand to new indications

Constructed a value proposition and IMSS (Mexico) access plan for a novel multiple sclerosis (MS) therapy

Identified and mapped KOLs and COEs, and assessed therapeutic approach and drivers of adoption to inform launch strategy for a mid-sized pharmaceutical company seeking to launch internationally

Developed a value proposition for an EGFR-targeting biologic intended to be marked by a large international pharmaceutical company to present to IMSS in Mexico

Physician targeting by field force based on recent cancer diagnoses 

Knowledge management system design for launch and go-to-market excellence

Disease area factbook creation for a peri-launch Hem-Onc asset